Carregant...
Clinical Outcomes Based on the Timing of Appearance of Visible Lesions in Barrett’s Esophagus During Endoscopic Eradication Therapy
BACKGROUND AND GOALS: Visible lesions (VLs) in Barrett’s esophagus (BE) are seen in 70% to 90% of patients presenting for endoscopic eradication therapy (EET). It is not known if there are any differences in outcomes of patients with flat dysplasia versus patients with VL. Our aim was to assess outc...
Guardat en:
| Publicat a: | J Clin Gastroenterol |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7050469/ https://ncbi.nlm.nih.gov/pubmed/30614938 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MCG.0000000000001165 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|